BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12898648)

  • 1. Binding of 3-hydroxybenzo[a]pyrene to bovine hemoglobin and albumin.
    Sugihara N; James MO
    J Biochem Mol Toxicol; 2003; 17(4):239-47. PubMed ID: 12898648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal bioavailability and biotransformation of 3-hydroxybenzo(a)pyrene in an isolated perfused preparation from channel catfish, Ictalurus punctatus.
    James MO; Tong Z; Rowland-Faux L; Venugopal CS; Kleinow KM
    Drug Metab Dispos; 2001 May; 29(5):721-8. PubMed ID: 11302939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A toxicokinetic study to elucidate 3-hydroxybenzo(a)pyrene atypical urinary excretion profile following intravenous injection of benzo(a)pyrene in rats.
    Marie C; Bouchard M; Heredia-Ortiz R; Viau C; Maître A
    J Appl Toxicol; 2010 Jul; 30(5):402-10. PubMed ID: 20186696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach for measuring protein adducts from benzo[a]pyrene diolepoxide by high performance liquid chromatography/tandem mass spectrometry.
    Helleberg H; Törnqvist M
    Rapid Commun Mass Spectrom; 2000; 14(18):1644-53. PubMed ID: 10962485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
    Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
    Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo(a)pyrenediolepoxide-hemoglobin adducts and 3-hydroxy-benzo(a)pyrene urinary excretion profiles in rats subchronically exposed to benzo(a)pyrene.
    Bouchard M; Viau C
    Arch Toxicol; 1995; 69(8):540-6. PubMed ID: 8534197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of the internal kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker from rat data.
    Heredia-Ortiz R; Bouchard M; Marie-Desvergne C; Viau C; Maître A
    Toxicol Sci; 2011 Aug; 122(2):275-87. PubMed ID: 21613232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between biomarkers of polycyclic aromatic hydrocarbon exposure and electrophilic tissue burden in a rat model.
    Tzekova A; Thuot R; Viau C
    Arch Toxicol; 2004 Jun; 78(6):351-61. PubMed ID: 14749914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Diol and Hydroxybenzo[a]pyrene Metabolites in Relation to DNA Adduct Formation and Gene Expression in Rats.
    Moreau M; Ayotte P; Bouchard M
    J Toxicol Environ Health A; 2015; 78(12):725-46. PubMed ID: 26090558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion kinetics of urinary 3-hydroxybenzo[a]pyrene following dietary exposure to benzo[a]pyrene in humans.
    Chien YC; Yeh CT
    Arch Toxicol; 2012 Jan; 86(1):45-53. PubMed ID: 21785897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.
    Sallustio BC; Fairchild BA; Pannall PR
    Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of hemoglobin and albumin adducts of benzo(a)pyrenediolepoxide and their rate of elimination in the female Sprague-Dawley rat.
    Viau C; Mercier M; Blondin O
    Arch Toxicol; 1993; 67(7):468-72. PubMed ID: 8239995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout.
    Miranda CL; Chung WG; Wang-Buhler JL; Musafia-Jeknic T; Baird WM; Buhler DR
    Aquat Toxicol; 2006 Nov; 80(2):101-8. PubMed ID: 16963132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
    Mandal R; Kalke R; Li XF
    Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric studies of cisplatin-induced changes of hemoglobin.
    Mandal R; Kalke R; Li XF
    Rapid Commun Mass Spectrom; 2003; 17(24):2748-54. PubMed ID: 14673822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of hemoglobin acetaldehyde adducts by high-performance liquid chromatography-cation-exchange chromatography.
    Itälä L; Seppä K; Turpeinen U; Sillanaukee P
    Anal Biochem; 1995 Jan; 224(1):323-9. PubMed ID: 7710090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 3-Hydroxybenzo[a]pyrene Glucuronide/Sulfate Conjugates in Human Urine and Their Association with 8-Hydroxydeoxyguanosine.
    Luo K; Gao Q; Hu J
    Chem Res Toxicol; 2019 Jul; 32(7):1367-1373. PubMed ID: 31204473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of hemoglobin and albumin adducts in rabbits subchronically exposed to benzo[a]pyrene.
    Viau C; Carrier G
    Fundam Appl Toxicol; 1995 Jan; 24(1):140-4. PubMed ID: 7713337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically-based pharmacokinetic modeling of benzo(a)pyrene and the metabolite in humans of different ages.
    Deng L; Liu H; Deng Q
    Int J Environ Health Res; 2021 Mar; 31(2):202-214. PubMed ID: 31296039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.